Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 15;11(9):2323.
doi: 10.3390/microorganisms11092323.

The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children

Affiliations
Review

The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children

Mayuri Prabakaran et al. Microorganisms. .

Abstract

Cryptosporidium species and Giardia duodenalis are infectious intestinal protozoan pathogens that cause alarming rates of morbidity and mortality worldwide. Children are more likely to have clinical symptoms due to their less developed immune systems and factors such as undernutrition, especially in low- and middle-income countries. The severity of the symptoms and clinical manifestations in children may vary from asymptomatic to life-threatening depending on the Cryptosporidium species/G. duodenalis strains and the resulting complex stepwise interactions between the parasite, the host nutritional and immunologic status, and the gut microbiome profile. Structural damages inflicted by both parasites to epithelial cells in the large and small intestines could severely impair children's gut health, including the ability to absorb nutrients, resulting in stunted growth, diminished neurocognitive development, and other long-term effects. Clinically approved cryptosporidiosis and giardiasis drugs have broad antimicrobial effects that have incomprehensible impacts on growing children's gut health.

Keywords: children’s gut health; cryptosporidiosis and giardiasis; gut microbiota; immunocompromised; undernutrition.

PubMed Disclaimer

Conflict of interest statement

Wesley C. Van Voorhis is the president and co-owner of ParaTheraTech Inc., a company that is developing BKIs for animal health. Van Voorhis edited this paper. The other authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
This is a simplified figure showing similarities in the life-cycle stages that initiate human infection and outbreaks of Cryptosporidium and G. duodenalis. The figure also shows the differences in their impacts on epithelial cells as a result of infection. Adapted from “Cryptosporidium Infection Cycle” by Biorender.com (28 August 2023).
Figure 2
Figure 2
Blender software version 3.5.1-generated image showing a host infected with Cryptosporidium (left) and Giardia (right). Cryptosporidium and/or G. duodenalis infection could alter the gut microbiota ecological balance (colored particles) through dysbiosis in the mucosal layers of epithelial cells. Giardia duodenalis cysteine proteases, beta-N-acetylglucosaminidase, and beta-N-acetylgalactosaminidase can efficiently break down mucins, which are the molecular framework of the epithelial mucosal layers on the intestine. Histological evidence of the marked depletion of intracellular mucin and gastrointestinal mucosal injury have been reported in HIV-positive individuals with cryptosporidiosis [74].

References

    1. Abbafati C., Abbas K.M., Abbasi M., Abbasifard M., Abbasi-Kangevari M., Abbastabar H., Abd-Allah F., Abdelalim A., Abdollahi M., Abdollahpour I., et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. - PMC - PubMed
    1. Lanata C.F., Fischer-Walker C.L., Olascoaga A.C., Torres C.X., Aryee M.J., Black R.E., Child Health Epidemiology Reference Group of the World Health Organization and UNICEF Global causes of diarrheal disease mortality in children <5 years of age: A systematic review. PLoS ONE. 2013;8:e72788. doi: 10.1371/journal.pone.0072788. - DOI - PMC - PubMed
    1. Okeke I.N., Nataro J.P. Enteroaggregative Escherichia coli. Lancet Infect. Dis. 2001;1:304–313. doi: 10.1016/S1473-3099(01)00144-X. - DOI - PubMed
    1. Bruzzese E., Giannattasio A., Guarino A. Antibiotic treatment of acute gastroenteritis in children. F1000Research. 2018;7:193. doi: 10.12688/f1000research.12328.1. - DOI - PMC - PubMed
    1. Kotloff K.L. Bacterial diarrhoea. Curr. Opin. Pediatr. 2022;34:147–155. doi: 10.1097/MOP.0000000000001107. - DOI - PubMed

LinkOut - more resources